Ken Griffin Evolent Health, Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$29.41 - $34.72 $138,227 - $163,184	-4,700 Reduced 16.97%	23,000 $754,000
Q4 2023 Feb 14, 2024	BUY	$23.63 - $33.52 $321,368 - $455,872	13,600 Added 96.45%	27,700 $914,000
Q3 2023 Nov 14, 2023	BUY	$25.0 - $31.4 $72,500 - $91,060	2,900 Added 25.89%	14,100 $383,000
Q2 2023 Aug 14, 2023	SELL	$28.05 - $36.44 $849,915 - $1.1 Million	-30,300 Reduced 73.01%	11,200 $339,000
Q1 2023 May 15, 2023	BUY	$26.35 - $35.8 $274,040 - $372,319	10,400 Added 33.44%	41,500 $1.35 Million

Q4 2022 Feb 14, 2023	SELL	$22.21 - $37.41 $635,206 - $1.07 Million	-28,600 Reduced 47.91%	31,100 $873,000
Q3 2022 Nov 14, 2022	BUY	$29.37 - $39.74 $1.18 Million - $1.6 Million	40,200 Added 206.15%	59,700 $2.15 Million

268

107M

370K

226K

Ticker EVH
Exchange NYSE
Sector Healthcare
Industry Health Information Services
Shares Outstandng 97,063,696
Market Cap $1.86B
Description
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.